» Articles » PMID: 22438185

Ex Vivo Expansion of Umbilical Cord Blood: Where Are We?

Overview
Journal Int J Hematol
Specialty Hematology
Date 2012 Mar 23
PMID 22438185
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Since the first successful clinical use of umbilical cord blood (UCB) in 1988, UCB grafts have been used for over 20,000 patients with both malignant and non-malignant diseases. UCB has several practical advantages over other transplantable graft sources. For example, the ease of procurement, the absence of donor risks, the reduced risk of transmissible infections, and the availability for immediate use make UCB an appealing graft choice. However, UCB grafts suffer from a few limitations related to the limited cell dose available for transplantation in each UCB unit and to defects in UCB stem cell homing. These limitations lead to increased post-transplant complications. In this review, we focus on the issue of limited cell dose in UCB units and discuss the possible approaches to overcome this limitation. We also summarize the various cellular pathways that have been explored to expand UCB units.

Citing Articles

An Overview on Human Umbilical Cord Blood Stem Cell-Based Alternative In Vitro Models for Developmental Neurotoxicity Assessment.

Singh A, Kashyap M Mol Neurobiol. 2015; 53(5):3216-3226.

PMID: 26041658 DOI: 10.1007/s12035-015-9202-6.


A novel application for a 3-dimensional timelapse assay that distinguishes chemotactic from chemokinetic responses of hematopoietic CD133(+) stem/progenitor cells.

Pepperell E, Watt S Stem Cell Res. 2013; 11(2):707-20.

PMID: 23727446 PMC: 3744817. DOI: 10.1016/j.scr.2013.04.006.


Umbilical cord blood transplantation supported by third-party donor cells: rationale, results, and applications.

Van Besien K, Liu H, Jain N, Stock W, Artz A Biol Blood Marrow Transplant. 2012; 19(5):682-91.

PMID: 23142329 PMC: 3618995. DOI: 10.1016/j.bbmt.2012.11.001.

References
1.
Butler J, Nolan D, Vertes E, Varnum-Finney B, Kobayashi H, Hooper A . Endothelial cells are essential for the self-renewal and repopulation of Notch-dependent hematopoietic stem cells. Cell Stem Cell. 2010; 6(3):251-64. PMC: 2866527. DOI: 10.1016/j.stem.2010.02.001. View

2.
Goessling W, Allen R, Guan X, Jin P, Uchida N, Dovey M . Prostaglandin E2 enhances human cord blood stem cell xenotransplants and shows long-term safety in preclinical nonhuman primate transplant models. Cell Stem Cell. 2011; 8(4):445-58. PMC: 3148081. DOI: 10.1016/j.stem.2011.02.003. View

3.
Dexter T, ALLEN T, LAJTHA L . Conditions controlling the proliferation of haemopoietic stem cells in vitro. J Cell Physiol. 1977; 91(3):335-44. DOI: 10.1002/jcp.1040910303. View

4.
Van Den Berg D, Sharma A, Bruno E, Hoffman R . Role of members of the Wnt gene family in human hematopoiesis. Blood. 1998; 92(9):3189-202. View

5.
Gluckman E, Broxmeyer H, Auerbach A, Friedman H, Douglas G, Devergie A . Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med. 1989; 321(17):1174-8. DOI: 10.1056/NEJM198910263211707. View